Search Results

Test Catalog

LAMO - Overview: Lamotrigine, Serum

Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine

LD - Overview: Lactate Dehydrogenase (LDH), Serum

Investigation of a variety of diseases involving the heart, liver, muscle, kidney, lung, and blood Monitoring changes in tumor burden after chemotherapy; lactate dehydrogenase elevations in patients with cancer are too erratic to be of use...

RAMBO - Overview: Ammonium, Random, Urine

Diagnosis of the cause of acidosis using random urine specimens Diagnosis and treatment of kidney stones

MMLRG - Overview: Antimicrobial Susceptibility, Acid-Fast Bacilli, Rapidly Growing, Varies

Determination of susceptibility of rapidly growing mycobacteria to the antimicrobial agents on the test panel

F_11 - Overview: Coagulation Factor XI Activity Assay, Plasma

Diagnosing deficiency of coagulation factor XI Investigating prolonged activated partial thromboplastin time

OMHC - Overview: Oxcarbazepine Metabolite, Serum

Monitoring serum concentration during oxcarbazepine therapy Assessing compliance Assessing potential toxicity

CK - Overview: Creatine Kinase (CK), Serum

Diagnosing and monitoring myopathies or other trauma, toxin, or drug-induced muscle injury

CNSA - Overview: Central Nervous System Consultation, Autopsy, Varies

Evaluation of congenital neurological disease Evaluation of neurodegenerative disease Evaluation of cases with a complex neurological or neurosurgical history Evaluation of sudden unexplained death This test is not intended for...

CEA - Overview: Carcinoembryonic Antigen (CEA), Serum

Monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma May be useful in assessing the effectiveness of chemotherapy or radiation treatment This test is not useful for screening the general population...

DULOX - Overview: Duloxetine, Serum

Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance

PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine

Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...

CIFS - Overview: Cutaneous Immunofluorescence Antibodies, IgG, Serum

Confirming the presence of IgG antibodies to diagnose of pemphigoid, pemphigus, epidermolysis bullosa acquisita, or bullous lupus erythematosus

IFXED - Overview: Immunofixation Heavy Chain Type Delta and Epsilon, Serum

Identification and isotyping of IgD or IgE monoclonal gammopathy Documentation of complete response to therapy with established monoclonal gammopathy consisting of an IgD or IgE heavy chain

GLURA - Overview: Glucose, Random, Serum

Diagnosing and managing diabetes mellitus and other carbohydrate metabolism disorders including gestational diabetes, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma

MNCU - Overview: Manganese/Creatinine Ratio, Urine

Measurement of manganese as a part of a profile Monitoring manganese exposure Nutritional monitoring Clinical trials

PGN - Overview: Pregabalin, Serum

Monitoring serum pregabalin (Lyrica) concentrations, assessing compliance, and adjusting dosage in patients

GLUR1 - Overview: Glucose, Random, Urine

Limited usefulness for routine screening or management of diabetes mellitus

RPCWT - Overview: Renal Pathology Consultation, Wet Tissue

Evaluating and managing patients with kidney disease Following the progression of known kidney disease or response to therapy Determining the cause of dysfunction in the transplanted kidney (allograft)

WILMP - Overview: Hereditary Wilms Tumor Panel, Varies

Evaluating isolated and syndromic causes of Wilms tumor Establishing a diagnosis to guide management for individuals with Wilms tumor Identifying a familial variant allowing for predictive testing and appropriate screening of at-risk...

HPFLU - Overview: Influenza Virus Type A and Type B and Respiratory Syncytial Virus (RSV) RNA, Molecular Detection, PCR, Varies

Simultaneous detection of influenza A virus, influenza B virus, and respiratory syncytial virus in upper or lower respiratory tract specimens from individuals with flu-like illnesses

CORAB - Overview: Hepatitis B Virus Core Total Antibodies, with Reflex to Hepatitis B Virus Core IgM Antibody, Serum

Detection and differentiation between recent, past/resolved, or chronic hepatitis B Diagnosis of recent hepatitis B virus (HBV) infection during the "window period" when both hepatitis B surface (HBs) antigen and anti-HBs are negative...

HCVL - Overview: Hepatitis C Virus Antibody Confirmation, Serum

Confirming the presence of hepatitis C virus (HCV)-specific IgG antibodies in serum specimens that are reactive by HCV antibody screening tests Distinguishing between true- and false-reactive HCV antibody screening test results This test...

NAIFA - Overview: Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum

Evaluation of patients suspected of having systemic autoimmune rheumatic disease (ANA-associated rheumatic diseases or connective tissue disease) or organ-specific autoimmune diseases such as autoimmune liver diseases

NMOFC - Overview: Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Spinal Fluid

Diagnosis of a neuromyelitis optica spectrum disorder (NMOSD) Diagnosis of autoimmune AQP4 channelopathy Distinguishing NMOSD from multiple sclerosis early in the course of disease

Site Search

Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights

Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....

NELL-1 [Test in Focus] - Insights

D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...

Looking Back on Clinical Chemistry 1 - Insights

in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....

Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....

Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights

test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....